Institut Français de Micro-immunothérapie IFMi
IFMi is a French non-profit association that promotes micro-immunotherapy through training (ForMi), a multimedia library (WikiMi), a medical platform (HelpMi), and personalized practitioner support (MeetMi), serving 250+ members and 1,550+ practitioners across francophone Europe.
- Company typePrivate
- Founded-
- HeadquartersParis, France
- Headcount1–10
- GTM typeB2B
- OfferingServices
What Institut Français de Micro-immunothérapie IFMi does
Institut Français de Micro-immunothérapie (IFMi) is a French non-profit association (loi 1901) headquartered in Paris that promotes micro-immunotherapy, a form of low-dose immunotherapy, to healthcare professionals and the broader francophone public. The institute operates a four-product digital ecosystem for practitioners: ForMi (continuing education and training), WikiMi (a multimedia library with 300+ content items and 10+ magazines), HelpMi (a medical information platform), and MeetMi (personalized practitioner support). It serves a community of 250+ members and 1,550+ registered practitioners, primarily in France, Switzerland, and other francophone regions, and has processed 750+ patient requests through its medical platform.
The institute's business model is membership- and training-centric. Revenue is generated through annual membership dues, training program fees (Qualiopi-certified, meaning French public training funds can be applied), magazine and publication sales, and premium digital content. The operational footprint is small at 8 employees, with Emmanuel Dubuisson serving as Publication Director. The organization is GDPR/RGPD compliant and operates as a non-profit, reinvesting any surplus into its educational and publishing mission.
IFMi has pursued international expansion through partnerships with AEMI (Spain), MeGeMIT (Austria), and the Swiss Mountain Clinic, extending micro-immunotherapy education and clinical practice into additional European markets. Its differentiation rests on a proprietary body of curated micro-immunotherapy content, a recognized training certification, and a multi-sided community of practitioners and patients, rather than on technological or AI-driven capabilities.
Institut Français de Micro-immunothérapie IFMi firmographics
Firmographics- Name
- Institut Français de Micro-immunothérapie IFMi
- Legal name
- Institut Français de Micro-immunothérapie (IFMi)
- Website
- https://microimmuno.fr
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- IFMi is a French non-profit association that promotes micro-immunotherapy through training (ForMi), a multimedia library (WikiMi), a medical platform (HelpMi), and personalized practitioner support (MeetMi), serving 250+ members and 1,550+ practitioners across francophone Europe.
- Ownership category
- akta.pro rank
Where Institut Français de Micro-immunothérapie IFMi is headquartered
LocationHeadquarters
- HQ city
- Paris
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
Institut Français de Micro-immunothérapie IFMi business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Annual Membership (Adhésion): Healthcare professionals pay an annual membership fee to join IFMi, which grants access to the professional platform and discounted rates on training, publications, and other services. Membership renews automatically via PayPal, Stripe, check, or bank transfer.
- Training and Seminar Fees: IFMi sells seats to its training seminars and online/in-person courses in micro-immunotherapy, available exclusively to healthcare professionals and health students. Revenue is recognized per registration, with availability limited by seating capacity.
- Publications and Educational Products: IFMi sells publications (magazines, books, documents) and other educational products. Some publications are available to the general public while others are restricted to health professionals. Orders are shipped domestically within 24 hours and internationally with varying delivery times.
- Professional Services (replays, premium content): Full access to services and products including replays and preferential pricing requires membership. Non-members may access certain services and products without membership.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Annual membership with preferential pricing |
| Freemium | Pay-as-you-go | Free professional space with webinars and limited access |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
Institut Français de Micro-immunothérapie IFMi product offering
Product offeringCore offering
IFMi is a French non-profit association (loi 1901) headquartered in Paris that promotes micro-immunotherapy, a therapeutic approach using low-dose immune-modulating substances. It delivers certified training programs, a multimedia scientific library, expert medical guidance, and a practitioner referral directory primarily to licensed healthcare professionals, with secondary patient-facing information services in French-speaking markets.
Product overview
IFMi (Institut Français de Micro-immunothérapie) is a professional healthcare association dedicated to micro-immunotherapy, operating as a platform with multiple integrated services: the Espace Professionnel serves as the central hub providing access to training (ForMi), a multimedia library (WikiMi with 300+ contents), a medical consultation platform (HelpMi), and personalized support (MeetMi). The institute also offers the Qualiopi-certified Formation Générale en Micro-immunothérapie for healthcare professionals, maintains patient-facing services including a practitioner finder and educational blog, and publishes scientific journals and magazines. The ecosystem is designed to support both practitioners in integrating micro-immunotherapy into their clinical practice and patients in understanding and accessing this therapeutic approach.
Differentiator
Problem solved
Functional benefit
Products and services
- Espace Professionnel (Espace Pro)
- Formation Générale en Micro-immunothérapie
- ForMi (Formations)
- WikiMi (Bibliothèque Multimédia)
- HelpMi (Plateforme Médicale)
- MeetMi (Accompagnement Personnalisé)
- Trouver un micro-immunothérapeute
- Revue MICRO-IMMUNO / LE MAG
Companies that use Institut Français de Micro-immunothérapie IFMi
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles3 records
Institut Français de Micro-immunothérapie IFMi technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Institut Français de Micro-immunothérapie IFMi partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core and minor.
- Asociación Española de la Microinmunoterapia (AEMI)coreAEMI is a Spanish association based in Barcelona (Av. Portal de l'Àngel, 36, 08002 Barcelona) pursuing the same objectives as IFMi — promoting and developing micro-immunotherapy education. The two organizations share testimonials and educational content and collaborate on advancing the recognition of micro-immunotherapy in the Spanish-speaking and francophone communities. IFMi explicitly shares patient and practitioner data with AEMI for educational and informative purposes.
- Medizinischen Gesellschaft für Mikroimmuntherapie (MeGeMIT)coreMeGeMIT is a German-speaking medical society for micro-immunotherapy based in Vienna, Austria (SPACES/Gertrude-Fröhlich-Sandner-Str. 2, Tower 9, 1100 Vienna). The Swiss Mountain Clinic and other practitioners reference the MeGeMIT approach alongside IFMi methodology, indicating harmonized clinical frameworks. IFMi shares data with MeGeMIT for joint educational and informative publications.
- Swiss Mountain ClinicminorThe Swiss Mountain Clinic in the canton of Graubünden, Switzerland, is directed by Drs. Petra and Frederike Wiechel, specialists in biological and integrative medicine. The clinic integrates micro-immunotherapy (MeGeMIT approach) as a core therapeutic tool within its holistic treatment environment featuring gluten-free meals, pure water, and low electrosmog.
- MSM Web SolutionsminorWeb design and SEO service provider credited for the design and search engine optimization of the IFMi website (microimmuno.fr).
- OVHminorWebsite hosting provider. The IFMi website is hosted on OVH servers located at 2 rue de Kellermann, 59100 Roubaix, France.
- StripeminorOnline payment processing platform used for credit card payments on the IFMi website. No banking details are stored by IFMi.
- PayPalminorOnline payment platform available for website orders and automatic membership renewal payments.
- CM2CminorConsumer dispute resolution mediator designated by IFMi for amicable resolution of consumption disputes, as required by French consumer law. Contactable by post at 49 Rue de Ponthieu, 75008 Paris or by email at [email protected].
Scale indicators7 records
Recent moves5 records
Expansion highlights5 records
Institut Français de Micro-immunothérapie IFMi competitors and assessment
Company assessmentOthers
- International Society for Complementary Medicine Research (ISCMR): Global research organization for complementary and integrative medicine. Functionally adjacent as an enabling/credibility-granting institution where IFMi-affiliated research could be published; serves the same scientific community but on an academic rather than practitioner-training track.
Regional players
- Institut National de Médecine Naturelle et Sportive (INMNS): French training organization dedicated to integrative and natural medicine education for healthcare professionals, with a similar mission of credentialing practitioners in complementary therapies. Comparable practitioner-focused GTM.
Broad incumbents
- Société Française de Médecine Intégrative (SFMI): French learned society promoting integrative medicine, including training and educational resources for integrative practitioners. Comparable operating model with broader scope, serving as a peer society for IFMi's practitioner audience.
- GLEM (Groupements pour l'Étude et l'Enseignement de la Médecine): Federation of French medical study groups providing continuing education to physicians across complementary medicine modalities, including homeopathy, acupuncture, and nutrition. Operates a similar practitioner-training business model with comparable Qualiopi-aligned certification.
- CEDH (Centre d'Enseignement et de Développement de l'Homéopathie): Major French homeopathy training institute offering a comparable continuing-education model for healthcare professionals in a complementary medicine discipline. Directly comparable GTM (practitioner training, Qualiopi-certified curriculum, professional community) operating in an adjacent complementary therapy.
Direct peers
- Asociación Española de Microinmunoterapia (AEMI): Spanish sister organization of IFMi, pursuing identical objectives of promoting and developing micro-immunotherapy education in the Spanish-speaking market. Mutual partnership with IFMi for shared content and educational collaboration.
- Medizinische Gesellschaft für Mikroimmuntherapie (MeGeMIT): Vienna-based German-speaking medical society for micro-immunotherapy, harmonized clinically with IFMi methodology. Direct peer operating the same micro-immunotherapy training framework in the DACH region.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Institut Français de Micro-immunothérapie IFMi social profiles
Digital presenceInstitut Français de Micro-immunothérapie IFMi compliance and trust
Trust signalCompliance2 records
Institut Français de Micro-immunothérapie IFMi financial estimates
Financial estimateRevenue estimate
Valuation estimate
Institut Français de Micro-immunothérapie IFMi leadership team
Management profileNumber of profiles
Profiles1 record
Institut Français de Micro-immunothérapie IFMi funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Institut Français de Micro-immunothérapie IFMi M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Institut Français de Micro-immunothérapie IFMi
What does Institut Français de Micro-immunothérapie IFMi do?
IFMi is a French non-profit association (loi 1901) headquartered in Paris that promotes micro-immunotherapy, a therapeutic approach using low-dose immune-modulating substances. It delivers certified training programs, a multimedia scientific library, expert medical guidance, and a practitioner referral directory primarily to licensed healthcare professionals, with secondary patient-facing information services in French-speaking markets.
Is Institut Français de Micro-immunothérapie IFMi a public or private company?
Institut Français de Micro-immunothérapie IFMi is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Institut Français de Micro-immunothérapie IFMi founded?
Institut Français de Micro-immunothérapie IFMi was founded in -1. It employs 1 to 10 people.
Where is Institut Français de Micro-immunothérapie IFMi based?
Institut Français de Micro-immunothérapie IFMi is headquartered in Paris, France, in the Europe region.
How does Institut Français de Micro-immunothérapie IFMi make money?
Four revenue lines are on record. Annual Membership (Adhésion) is the primary driver. The others are training and Seminar Fees, publications and Educational Products and professional Services (replays, premium content).
Who are Institut Français de Micro-immunothérapie IFMi's main competitors?
International Society for Complementary Medicine Research (ISCMR) is listed as an others. Institut National de Médecine Naturelle et Sportive (INMNS) is listed as a regional player. Broad incumbents are Société Française de Médecine Intégrative (SFMI), GLEM (Groupements pour l'Étude et l'Enseignement de la Médecine) and CEDH (Centre d'Enseignement et de Développement de l'Homéopathie). Direct peers are Asociación Española de Microinmunoterapia (AEMI) and Medizinische Gesellschaft für Mikroimmuntherapie (MeGeMIT).
Does Institut Français de Micro-immunothérapie IFMi have an API?
No public API is recorded for Institut Français de Micro-immunothérapie IFMi.